Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific Diabetes care device market saw a short term impact of COVID-19 in 2020. Beyond the pandemic, moderate growth is anticipated over the forecast period, driven by favorable demographics and the adoption of advanced products—such as hybrid closed-loop insulin pumps—that command a premium price. However, the markets—particularly in China and India—continue to be limited by strong cost constraints that impede the uptake of premium-priced products.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for diabetes care devices in the Asia Pacific from 2019 through 2031.
The COVID-19 pandemic has had minimal impact on the Asia Pacific diabetes care device market.
To what extent has the COVID-19 pandemic impacted the diabetes care device market in the Asia Pacific?
How is recovery varying by segment?
When will the market exhibit pre-pandemic growth?
Countries in the Asia Pacific region have varying adoption rates of insulin pumps, but there is little correlation between market and population size.
Which countries have seen the greatest adoption of insulin pumps and why?
Which market has the largest opportunity for growth?
Partnerships between companies are prevalent in the diabetes care device market.
Which companies have entered into mutually beneficial partnerships?
What products are these companies developing? What advantages will these products have over devices already on the market?
The insulin delivery device market is large and will continue to expand rapidly.
What are new innovations are emerging in this segment?
What factors are driving growth in this market?
Which types of devices are seeing the strongest adoption, and how are these trends affecting other product segments?
The rise in innovation and emerging technologies will impact the diabetes care device market significantly.
Which new products are entering the Asia Pacific market, and how will these launches impact the market and competitive landscapes?
In which countries will new devices launch first?
What regulatory and economic factors drive and limit the uptake of novel devices in the Asia Pacific countries?
Table of contents
- Diabetes Care Devices - Market Insights - Asia Pacific
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- COVID-19 Analysis
- Diabetes Care Device Market
- Glucose Monitoring Device Market
- Insulin Delivery Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Diagnosed Prevalent Diabetes Patients, by Treatment Type, Asia Pacific, 2019u20132031
- Insulin Delivery Device Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Insulin Delivery Device Market, by Country, Asia Pacific (USD), 2019u20132031
- Multiple Daily Injection Devices
- Conventional Pumps and Accessories
- Market Share Rankings
- Competitive Insights
- Appendix
Suchitra Ghoshal is an associate healthcare research & data analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Clarivate, specializing in the biosurgical agent market. Suchitra holds a Bachelor’s degree in Life Sciences from Delhi University, and a Master’s degree in Environmental Science from Guru Gobind Singh Indraprastha University, New Delhi.